| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/30/2005 | CN1600854A New diatom manganese type superoxide dismutase and usage |
| 03/30/2005 | CN1600852A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B |
| 03/30/2005 | CN1600851A Method for raising efficiency for producing transgenic animal |
| 03/30/2005 | CN1600850A Unit cell fungus, engineering fungus prepared through motion ferment and application |
| 03/30/2005 | CN1600849A Bacilluscoli 0157 gene deficiency bacterin of intestinal hemorrhage |
| 03/30/2005 | CN1600789A Promotive factor for activating NF-kappa B and usage |
| 03/30/2005 | CN1195064C Vector for gent transfer into plant allowing optional deletion of marker gene |
| 03/30/2005 | CN1195063C Proteinase inhibitor fusion proteins |
| 03/30/2005 | CN1195062C Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses |
| 03/30/2005 | CN1195061C Ethylene-insenstiive plant expression vector pBinETR1 and its use |
| 03/30/2005 | CN1195060C Nucleotide series of shaogengen mould delta-6 fatty acid dehydrogenase and its use |
| 03/30/2005 | CN1195056C Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method |
| 03/30/2005 | CN1195054C Nikemycin Z component engineering bacterium and its application |
| 03/30/2005 | CN1194991C Recombinant Toxoplasma fusion protein antigen and preparation process and use thereof |
| 03/30/2005 | CN1194990C Polypeptide motif bound with human CD95 and its polypeptide |
| 03/30/2005 | CN1194989C Novel human protein able to suppress cancer cell growth and its coding sequence |
| 03/30/2005 | CN1194986C Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof |
| 03/30/2005 | CN1194961C Process for refining amidate |
| 03/30/2005 | CN1194817C Method and device for applying plurality of microdroplets onto substrate |
| 03/29/2005 | US6872872 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
| 03/29/2005 | US6872871 Mapping molecular interactions in plants with protein fragments complementation assays |
| 03/29/2005 | US6872870 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 03/29/2005 | US6872869 Method for establishing an expression system of spider dragline silk gene in bombyx mori |
| 03/29/2005 | US6872818 Ammonium sulfate for neutralization of inhibitory effects |
| 03/29/2005 | US6872815 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 03/29/2005 | US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/29/2005 | US6872813 Genes coding for tomato β-galactosidase polypeptides |
| 03/29/2005 | US6872811 HRPCa9 and HRPCa10 nucleic acids and polypeptides |
| 03/29/2005 | US6872808 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 03/29/2005 | US6872807 Proteases from gram positive organisms |
| 03/29/2005 | US6872568 Death domain containing receptor 5 antibodies |
| 03/29/2005 | US6872564 Method of producing copolymer polyester |
| 03/29/2005 | US6872561 Forming viruses |
| 03/29/2005 | US6872560 Human hydrolytic enzymes |
| 03/29/2005 | US6872559 Diagnosis of urogenital disorders |
| 03/29/2005 | US6872558 Heparanase-2 a member of the heparanase protein family |
| 03/29/2005 | US6872557 Gene encoding novel human secretory phospholipase A2 |
| 03/29/2005 | US6872556 Invention provides DNAs, vectors and host cells for the efficient production of various enzymes in the mevalonate pathway or for converting isopentyl pyrophosphate to farnesyl pyrophosphate synthase |
| 03/29/2005 | US6872555 Nucleotide sequences for use in generating fructose polymers for food processing |
| 03/29/2005 | US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/29/2005 | US6872549 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free |
| 03/29/2005 | US6872548 Polypeptide for use in animal models associated with human therapeutics |
| 03/29/2005 | US6872547 Functional balanced-lethal host-vector systems |
| 03/29/2005 | US6872539 Detection of preferential microoganism in sample; obtain sample, incubate with propagation mixture, detect spore propagation |
| 03/29/2005 | US6872531 Composite material sheet for analysis of substances originating from living body or analogues thereof |
| 03/29/2005 | US6872528 Cell culture; for use as tool in gene therapy and cel packaging |
| 03/29/2005 | US6872527 Storing preferential nucleotide sequences on solid matrix; obtain nucleic acid sample, incubate with solid matrix, join nucleic acids to to matrix, recover matrix |
| 03/29/2005 | US6872526 Detecting activity of biopolymer; screen library of clones, encapsulate biocompatible substrate and in gel drop, monitor drop for preferential activity, detect adjustment in substrate, adjustment in substrate indicates active biopolymer |
| 03/29/2005 | US6872525 Method for selectively separating live cells expressing a specific gene |
| 03/29/2005 | US6872524 Method of detecting an expression-enhancing sequence |
| 03/29/2005 | US6872522 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
| 03/29/2005 | US6872521 Polymerase signaling assay |
| 03/29/2005 | US6872518 Therapeutic treatment of human tumors, cancers and infected cells; a viral vector containing a DNA insert as antitumor agents, anticarcinogenic agents, viricides, fungicides, bactericides |
| 03/29/2005 | US6872395 Viruses comprising mutant ion channel protein |
| 03/29/2005 | US6872393 Polyalkylene oxide-modified single chain polypeptides |
| 03/29/2005 | US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders |
| 03/29/2005 | US6872386 Immunization of aquatic animals against infectious diseases |
| 03/29/2005 | US6872385 Adjuvant preparation for the induction of specific immunity |
| 03/29/2005 | CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/29/2005 | CA2372409C Delivery of macromolecules into cells |
| 03/29/2005 | CA2344700C Method of plant transformation |
| 03/29/2005 | CA2323506C Mammalian blood loss-induced gene, kd312 |
| 03/29/2005 | CA2225831C Novel detection methods for cryptosporidium |
| 03/29/2005 | CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 03/29/2005 | CA2169282C Method of improving the yield of herbicide-resistant crop plants |
| 03/29/2005 | CA2139667C Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes |
| 03/29/2005 | CA2099619C Nucleotide sequences of soybean acyl-acp thioesterase genes |
| 03/29/2005 | CA2072023C Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for theses polypeptides, and their preparation and use |
| 03/29/2005 | CA2065346C Tumor necrosis factor-.alpha. and-.beta. receptors |
| 03/29/2005 | CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/24/2005 | WO2005026391A1 Method for gene identification signature (gis) analysis |
| 03/24/2005 | WO2005026390A1 Dna detection method using molecular beacon with the use of monomer fluorescence/excimer fluorescence switching of fluorescent molecule |
| 03/24/2005 | WO2005026388A2 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | WO2005026387A1 A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
| 03/24/2005 | WO2005026385A1 Hormone receptor genes and migraine susceptibility |
| 03/24/2005 | WO2005026375A2 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/24/2005 | WO2005026374A2 Method for synthesizing nucleic acids, and application thereof |
| 03/24/2005 | WO2005026371A1 Method of transferring biological substance and transformation method using the method of transferring biological substance |
| 03/24/2005 | WO2005026370A2 Multi-antigen vectors for melanoma |
| 03/24/2005 | WO2005026369A2 Interference rna expression vectors, methods for the production and use thereof |
| 03/24/2005 | WO2005026368A2 Dihydroflavonol-4-reductase |
| 03/24/2005 | WO2005026367A1 Overexpression of foreign genes in plants |
| 03/24/2005 | WO2005026366A1 Novel endosperm-specific plant promoter for cultivated plants |
| 03/24/2005 | WO2005026365A1 A thermophilic host-vector system |
| 03/24/2005 | WO2005026364A1 Selection system containing non-antibiotic resistance selection marker |
| 03/24/2005 | WO2005026363A1 Method of detecting mutation and method of inducing the same |
| 03/24/2005 | WO2005026362A2 Lymphatic and blood endothelial cell genes |
| 03/24/2005 | WO2005026361A1 Soluble ectodomain fragments of met and uses thereof |
| 03/24/2005 | WO2005026360A1 Cellular model of tauopathies for lead identification and drug discovery |
| 03/24/2005 | WO2005026359A2 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | WO2005026358A1 Polymorphisms in selenoprotein s |
| 03/24/2005 | WO2005026357A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 03/24/2005 | WO2005026356A1 Modified gene-silencing nucleic acid molecules and uses thereof |
| 03/24/2005 | WO2005026355A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026354A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026353A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026352A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026351A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026350A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026347A1 Method for isolating and purifying a nucleic acid |